<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Digital Diagnostics</journal-id><journal-title-group><journal-title xml:lang="en">Digital Diagnostics</journal-title><trans-title-group xml:lang="ru"><trans-title>Digital Diagnostics</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Digital Diagnostics</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2712-8490</issn><issn publication-format="electronic">2712-8962</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81617</article-id><article-id pub-id-type="doi">10.17816/DD81617</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original Study Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="zh"><subject>原创性科研成果</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Use of magnetic resonance imaging features as radiomic markers in pre-operative evaluation of extra-axial tumor grade</article-title><trans-title-group xml:lang="ru"><trans-title>Показатели магнитно-резонансной томографии как радиомные маркеры в дооперационном определении степени злокачественности внемозговых образований</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>磁共振成像指标作为术前确定脑外组织恶性程度的放射标记物</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1530-1327</contrib-id><contrib-id contrib-id-type="spin">5467-7347</contrib-id><name-alternatives><name xml:lang="en"><surname>Bergen</surname><given-names>Tatyana A.</given-names></name><name xml:lang="ru"><surname>Берген</surname><given-names>Татьяна Андреевна</given-names></name><name xml:lang="zh"><surname>Bergen</surname><given-names>Tatyana A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci (Med)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci (Med)</p></bio><email>tbergen@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3691-2848</contrib-id><contrib-id contrib-id-type="spin">8973-2982</contrib-id><name-alternatives><name xml:lang="en"><surname>Soynov</surname><given-names>Ilya A.</given-names></name><name xml:lang="ru"><surname>Cойнов</surname><given-names>Илья Александрович</given-names></name><name xml:lang="zh"><surname>Soynov</surname><given-names>Ilya A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci (Med)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci (Med)</p></bio><email>i_soynov@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2409-8500</contrib-id><contrib-id contrib-id-type="spin">4694-2576</contrib-id><name-alternatives><name xml:lang="en"><surname>Pustovetova</surname><given-names>Mariya G.</given-names></name><name xml:lang="ru"><surname>Пустоветова</surname><given-names>Мария Геннадьевна</given-names></name><name xml:lang="zh"><surname>Pustovetova</surname><given-names>Mariya G.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med), Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Med), Professor</p></bio><email>patophisiolog@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">E. Meshalkin National Medical Research Center</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр имени академика Е.Н. Мешалкина</institution></aff><aff><institution xml:lang="zh">E. Meshalkin National Medical Research Center</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2021-11-30" publication-format="electronic"><day>30</day><month>11</month><year>2021</year></pub-date><pub-date date-type="pub" iso-8601-date="2021-12-30" publication-format="electronic"><day>30</day><month>12</month><year>2021</year></pub-date><volume>2</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>431</fpage><lpage>440</lpage><history><date date-type="received" iso-8601-date="2021-10-02"><day>02</day><month>10</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-11-15"><day>15</day><month>11</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Bergen T.A., Soynov I.A., Pustovetova M.G.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Берген Т.А., Cойнов И.А., Пустоветова М.Г.</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2021, Bergen T., Soynov I., Pustovetova M.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Bergen T.A., Soynov I.A., Pustovetova M.G.</copyright-holder><copyright-holder xml:lang="ru">Берген Т.А., Cойнов И.А., Пустоветова М.Г.</copyright-holder><copyright-holder xml:lang="zh">Bergen T., Soynov I., Pustovetova M.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://jdigitaldiagnostics.com/DD/article/view/81617">https://jdigitaldiagnostics.com/DD/article/view/81617</self-uri><abstract xml:lang="en"><p><bold><italic>BACKGROUND: </italic></bold>Extra-axial tumors are one of the tumor groups with difficult primary differential diagnostics. Detection and standardization of radiomic markers are one of the main problems of our time<italic>.</italic></p> <p><bold><italic>AIM:</italic></bold> To detect radiomic markers for preoperative assessment of extra-axial tumor grade.</p> <p><bold><italic>MATERIALS AND METHODS: </italic></bold>This study retrospective analyzed the magnetic resonance imaging (1.5 T) data of 156 patients with extra-axial tumors. Patients were divided into 2 groups: Group 1 (<italic>n</italic>=106) with perifocal changes and Group 2 (<italic>n</italic>=50) with extra-axial tumors without perifocal changes. Diffusion and perfusion sequences were included in the scanning protocol. The areas of interest include (1) the lesion and (2) the area of perifocal changes. Measurements were made from the lesion and the area of perifocal changes on ACD and DSС maps, DCE was analyzed.</p> <p><bold><italic>RESULTS:</italic></bold> The maximum lesion size in Group 1 was 2.2 cm (1.4; 4.3), whereas in 1.2 cm in Group 2 (0.9; 3.5). In Group 1, the diffusion restriction from the lesion was detected in 42 patients (39.6%), whereas 7 (14%) in Group 2. The maximum size of perifocal changes in Group 1 was 2.85 cm (1.5; 4.7). Diffusion restriction was detected in 52 (49.1%) cases. In Group 1, patients with verified meningioma multivariable linear regression analysis showed 3.3-times increase of rCBF of the maximum size of the lesion from the area of perifocal changes (βcoef. 3.3, CI: 1.27; 5.28), <italic>p</italic>=0.003; however, it demonstrated a 4-time decrease of rCBF (βcoef. 4 CI: -7.46; -0.71), <italic>p</italic>=0.02.</p> <p><bold><italic>CONCLUSIONS:</italic></bold> Perfusion and diffusion methods combined with anatomical sequences show potential use as radiomic markers for diagnostic assessment and treatment of extra-axial tumors. Further detection of radiomic functional markers from the area of perifocal changes has potential.</p></abstract><trans-abstract xml:lang="ru"><p><bold><italic>Обоснование.</italic></bold> Внемозговые образования ― одна из наиболее сложных групп для первичной дифференциальной диагностики. Определение радиомных маркеров и их стандартизация являются основными базовыми проблемами современного этапа развития медицины.</p> <p><bold><italic>Цель</italic></bold> ― выявить радиомные маркеры для предоперационной оценки степени злокачественности внемозгового образования.</p> <p><bold><italic>Материалы и методы.</italic></bold> Ретроспективный анализ результатов исследований методом магнитно-резонансной томографии (1,5 Т) 156 пациентов с внемозговыми образованиями. Пациенты были разделены на 2 группы: (1) c наличием перифокальных изменений (<italic>n</italic>=106) и (2) внемозговым образованием без перифокальных изменений (<italic>n</italic>=50). В протокол сканирования были включены диффузионные и перфузионные последовательности. За зону интереса принимали (1) основной очаг и (2) зону перифокальных изменений. Выполнены измерения от основного очага и от зоны перифокальных изменений на картах измеряемого коэффициента диффузии, T2*-контрастной перфузии (DSС), проведен анализ серий динамического контрастирования (DCE).</p> <p><bold><italic>Результаты.</italic></bold> Максимальный размер основного очага (узла) поражения в 1-й группе составил 2,2 см (1,4; 4,3), во 2-й группе ― 1,2 см (0,9; 3,5); ограничение диффузии от основного очага поражения выявлено у 42 (39,6%) человек 1-й группы и у 7 (14%) ― 2-й. Максимальный размер перифокальных изменений в 1-й группе составил 2,85 см (1,5; 4,7). Ограничение диффузии от периферической зоны выявлено в 52 (49,1%) случаях. У пациентов 1-й группы с верифицированной менингиомой (<italic>n</italic>=66) путём многофакторного линейного регрессионного анализа выявлено, что максимальный размер основной зоны поражения увеличивал коэффициент объёмного кровотока (rCBF) от зоны перифокальных изменений в 3,3 раза (βcoef. 3,3, ДИ 1,27; 5,28; <italic>p</italic>=0,003), однако снижал показатель регионарного объёма крови (rCBV) в 4 раза (βcoef. 4, ДИ -7,46; -0,71; <italic>p</italic>=0,02).</p> <p><bold><italic>Заключение.</italic></bold> Перфузионные и диффузионные методы в сочетании с анатомическими последовательностями демонстрируют потенциал и могут выступать радиомическими маркерами при диагностике и лечении внемозговых образований. В дальнейшем наиболее перспективным выглядит выявление радиомических функциональных маркеров от зоны перифокальных изменений.</p></trans-abstract><trans-abstract xml:lang="zh"><p><italic><bold>论证。</bold></italic>脑外结构是最难进行初级鉴别诊断的组之一。 放射组标志物的测定及其标准化是现代医学发展阶段的主要基础问题。</p> <p><italic><bold>目的</bold></italic>是确定用于术前评估脑外肿块恶性程度的放射组标记。</p> <p><italic><bold>材料与方法。</bold></italic>回顾性分析使用磁共振成像 (1.5 T) 对 156 名脑外形成患者的研究结果。 将患者分为 2 组：（1）存在病灶周围改变（n=106）和（2）无病灶周围改变的脑外肿块（n=50）。 扩散和灌注序列包括在扫描协议中。 感兴趣的区域被定义为（1）主要焦点和（2）焦点周围变化的区域。从主焦点和测量扩散系数图上的焦周变化区域进行测量，T2*动态磁敏感对比 (DSC)，进行动态对比增强 (DCE) 系列分析。</p> <p><italic><bold>结果。</bold></italic>第 1 组主要病灶（结节）的最大尺寸为 2.2 厘米 （1.4；4.3），第 2 组的为 1.2 厘米 （0.9；3.5）； 第 1 组 42 人 (39.6%) 和第 2 组 7 人 (14%) 检测到主要病灶扩散受限。 第 1 组的最大焦周变化为 2.85 厘米 (1.5; 4.7)。 在 52 例 (49.1%) 病例中检测到来自外周区的扩散受限。 在第 1 组确诊脑膜瘤患者（n=66）中，多元线性回归分析显示，主要病变区的最大尺寸使病灶周围变化区的体积血流系数（rCBF）增加了 3.3 倍(βcoef. 3.3, CI 1.27; 5.28; p=0.003)，但将局部血容量 (rCBV) 降低了 4 倍 (βcoef. 4, CI -7.46; -0.71; p=0.02)。</p> <p><italic><bold>结论。</bold></italic>灌注和扩散方法与解剖序列相结合显示出潜力，可以作为诊断和治疗脑外病变的放射组学标志物。 未来，最有希望的是从焦周变化区域识别放射功能标志物。</p></trans-abstract><kwd-group xml:lang="en"><kwd>extra-axial tumors</kwd><kwd>meningioma</kwd><kwd>perifocal changes</kwd><kwd>malignancy grade</kwd><kwd>diffusion</kwd><kwd>perfusion</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>радиомика</kwd><kwd>внемозговое образование</kwd><kwd>менингиома</kwd><kwd>перифокальные изменения</kwd><kwd>степень злокачественности</kwd><kwd>диффузия</kwd><kwd>перфузия</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>放射组学</kwd><kwd>脑外教育</kwd><kwd>脑膜瘤</kwd><kwd>焦周变化</kwd><kwd>恶性程度</kwd><kwd>扩散</kwd><kwd>灌注</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Mahmoud MA, Shihab M, Saad SS, et al. Imaging differentiation of malignant hepatic tumors: radiomics and metabolic features of 18F-FDG PET/CT. REJR. 2021;11(2):165–170. doi: 10.21569/2222-7415-2021-11-1-230-237</mixed-citation><mixed-citation xml:lang="ru">Mahmoud M.A., Shihab M., Saad SS., et al. Imaging differentiation of malignant hepatic tumors: radiomics and metabolic features of 18F-FDG PET/CT // REJR. 2021. Vol. 11, N 2. Р. 165–170. doi: 10.21569/2222-7415-2021-11-1-230-237</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Lambin Ph, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48(4):441–446. doi: 10.1016/j.ejca.2011.11.036</mixed-citation><mixed-citation xml:lang="ru">Lambin Ph., Rios-Velazquez E., Leijenaar R., et al. Radiomics: extracting more information from medical images using advanced feature analysis // Eur J Cancer. 2012. Vol. 48, N 4. Р. 441–446. doi: 10.1016/j.ejca.2011.11.036</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Singh G, Manjila S, Sakla N, et al. Radiomics and radiogenomics in gliomas: a contemporary update. Br J Cancer. 2021;125(5):641–657. doi: 10.1038/s41416-021-01387-w</mixed-citation><mixed-citation xml:lang="ru">Singh G., Manjila S., Sakla N., et al. Radiomics and radiogenomics in gliomas: a contemporary update // Br J Cancer. 2021. Vol. 125, N 5. Р. 641–657. doi: 10.1038/s41416-021-01387-w</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Xiaoai K, Qing Z, Lei H, Junlin Z. Differentiating microcystic meningioma from atypical meningioma using diffusion-weighted imaging. Neuroradiology. 2020;62(5):601–607. doi: 10.1007/s00234-020-02374-3</mixed-citation><mixed-citation xml:lang="ru">Xiaoai K., Qing Z., Lei H., Junlin Z. Differentiating microcystic meningioma from atypical meningioma using diffusion-weighted imaging // Neuroradiology. 2020. Vol. 62, N 5. Р. 601–607. doi: 10.1007/s00234-020-02374-3</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Backer-Grøndahl T, Moen BH, Torp SH. The histopathological spectrum of human meningiomas. Int J Clin Exp Pathol. 2012;5(3):231–242.</mixed-citation><mixed-citation xml:lang="ru">Backer-Grøndahl T., Moen B.H., Torp S.H. The histopathological spectrum of human meningiomas // Int J Clin Exp Pathol. 2012. Vol. 5, N 3. Р. 231–242.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Aslan K, Gunbey HP, Tomak L, Incesu L. The diagnostic value of using combined MR diffusion tensor imaging parameters to differentiate between lowand high-grade meningioma. Br J Radiol. 2018;91(1088):20180088. doi: 10.1259/bjr.20180088</mixed-citation><mixed-citation xml:lang="ru">Aslan K., Gunbey H.P., Tomak L., Incesu L. The diagnostic value of using combined MR diffusion tensor imaging parameters to differentiate between lowand high-grade meningioma // Br J Radiol. 2018. Vol. 91, N 1088. Р. 20180088. doi: 10.1259/bjr.20180088</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Louis D, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803–820. doi: 10.1007/s00401-016-1545-1</mixed-citation><mixed-citation xml:lang="ru">Louis D., Perry A., Reifenberger G., et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary // Acta Neuropathol. 2016. Vol. 131, N 6. Р. 803–820. doi: 10.1007/s00401-016-1545-1</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Upadhyay N, Waldman A. Conventional MRI evaluation of gliomas. Br J Radiol. 2011;84(2):S107–S111. doi: 10.1259/bjr/65711810</mixed-citation><mixed-citation xml:lang="ru">Upadhyay N., Waldman A. Conventional MRI evaluation of gliomas // Br J Radiol. 2011. Vol. 84, N 2. Р. S107–S111. doi: 10.1259/bjr/65711810</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Hale A, Wang L, Strother M, Chambless L. Differentiating meningioma grade by imaging features on magnetic resonance imaging. J Clin Neuroscience. 2018;48:71–75. doi: 10.1016/j.jocn.2017.11.013</mixed-citation><mixed-citation xml:lang="ru">Hale A., Wang L., Strother M., Chambless L. Differentiating meningioma grade by imaging features on magnetic resonance imaging // J Clin Neuroscience. 2018. Vol. 48. Р. 71–75. doi: 10.1016/j.jocn.2017.11.013</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Schneider J, Kulason K, White T, et al. Management of tiny meningiomas: to resect or not resect. Cureus. 2017;9(7):е1514. doi: 10.7759/cureus.1514</mixed-citation><mixed-citation xml:lang="ru">Schneider J., Kulason K., White T., et al. Management of tiny meningiomas: to resect or not resect // Cureus. 2017. Vol. 9, N 7. Р. е1514. doi: 10.7759/cureus.1514</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Heye AK, Culling RD, Hernández MC, et al. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. Neuroimage Clin. 2014;6:262–274. doi: 10.1016/j.nicl.2014.09.002</mixed-citation><mixed-citation xml:lang="ru">Heye A.K., Culling R.D., Hernández M.C., et al. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review // Neuroimage Clin. 2014. Vol. 6. Р. 262–274. doi: 10.1016/j.nicl.2014.09.002</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Jelescu I, Leppert I, Narayanan S, et al. Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood-brain barrier permeability measurement in enhancing multiple sclerosis lesions. J Magnetic Resonance Imaging. 2011;33(6):1291–1300. doi: 10.1002/jmri.22565</mixed-citation><mixed-citation xml:lang="ru">Jelescu I., Leppert I., Narayanan S., et al. Dual-temporal resolution dynamic contrast-enhanced MRI protocol for blood-brain barrier permeability measurement in enhancing multiple sclerosis lesions // J Magnetic Resonance Imaging. 2011. Vol. 33, N 6. Р. 1291–1300. doi: 10.1002/jmri.22565</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Essig M, Shiroishi M, Nguyen T, et al. Perfusion MRI: the five most frequently asked technical questions. Am J Roentgenol. 2013;200(1):24–34. doi: 10.2214/ajr.12.9543</mixed-citation><mixed-citation xml:lang="ru">Essig M., Shiroishi M., Nguyen T., et al. Perfusion MRI: the five most frequently asked technical questions // Am J Roentgenol. 2013. Vol. 200, N 1. Р. 24–34. doi: 10.2214/ajr.12.9543</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Sourbron S, Buckley D. Classic models for dynamic contrast-enhanced MRI. NMR Biomed. 2013;26(8):1004–1027. doi: 10.1002/nbm.2940</mixed-citation><mixed-citation xml:lang="ru">Sourbron S., Buckley D. Classic models for dynamic contrast-enhanced MRI // NMR Biomed. 2013. Vol. 26, N 8. Р. 1004–1027. doi: 10.1002/nbm.2940</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Siempis T, Tsakiris C, Alexiou GA, et al. Diagnostic performance of diffusion and perfusion MRI in differentiating high from low-grade meningiomas: A systematic review and meta-analysis. Clin Neurol Neurosurg. 2020;190:105643. doi: 10.1016/j.clineuro.2019.105643</mixed-citation><mixed-citation xml:lang="ru">Siempis T., Tsakiris C., Alexiou G.A., et al. Diagnostic performance of diffusion and perfusion MRI in differentiating high from low-grade meningiomas: A systematic review and meta-analysis // Clin Neurol Neurosurg. 2020. Vol. 190. Р. 105643. doi: 10.1016/j.clineuro.2019.105643</mixed-citation></citation-alternatives></ref></ref-list></back></article>
